Effects of aloe vera supplements on blood glucose level and lipid profile markers in type 2 diabetic patients - A randomized clinical trial
MetadataShow full item record
Background: One of the most studied methods to adjust the blood glucose level and dyslipidemia in diabetic patients is administrating of herbal supplements. This double blinded randomized clinical trial (RCT) study we are aimed to study the effect of Aloe vera supplements on blood glucose level and lipid profile of diabetes mellitus type 2 patients. Methods: 44 patients (25 male and 19 female) fulfilling inclusion criteria, were divided into two groups of intervention and placebo randomly. The patients in intervention group received 1000 mg of Aloe vera supplements and the patients of placebo group received placebo, daily for two months beside the main treatment for diabetes mellitus. Before and after the intervention blood samples were taken from all the patients; and were measured for blood glucose level and lipid profile. The data were analyzed using independent T-test method. This RCT study was submitted in IRCT center by submitted code of IRCT201307269626N3. Results: The results revealed that the levels of the fasting blood sugar (FBS), HbA1c, Total Cholesterol, Triglyceride, high density lipoprotein (HDL), low density lipoprotein (LDL) were not significantly different between the pre-intervention and post intervention blood samples in both intervention and placebo group. Also there was not any significant difference in blood glucose level and lipid profile comparing intervention and placebo groups. Conclusion: In this study, we can conclude that Aloe vera supplement beside the main treatment for diabetes mellitus has no significant effect in blood glucose level and lipid profile in diabetes mellitus type 2 patients. © 2015 The Authors.
Showing items related by title, author, creator and subject.
Decreased Serum Levels of Ghrelin and Brain-Derived Neurotrophic Factor in Premenopausal Women with Metabolic Syndrome Jabbari, M; Kheirouri, S; Alizadeh, M (2018)Objective We aimed to investigate the association between serum levels of ghrelin and brain-derived neurotrophic factor (BDNF) with MetS and its components in premenopausal women. Methods 43 patients with MetS and 43 healthy ...
Relationship of serum resistin level with insulin resistance indices in non-diabetic and diabetic obese subjects Mohammadzadeh, G; Zarghami, N; Larijani, B (2007)Background: Resistin, an adipocyte secreted factor, has been suggested to link obesity with type 2 diabetes and insulin resistance in rodent models but its relevance to human diabetes remains uncertain. The aim of this ...
L-Carnosine supplementation attenuated fasting glucose, triglycerides, advanced glycation end products, and tumor necrosis factor-? levels in patients with type 2 diabetes: a double-blind placebo-controlled randomized clinical trial Houjeghani, S; Kheirouri, S; Faraji, E; Jafarabadi, MA (2018)Considering the pathologic importance of metabolic disturbances, advanced glycation end products (AGEs), and chronic inflammation in diabetes mellitus and ameliorating potentials of L-carnosine in hampering these detritions ...